Precancerous Condition: Clinical Trials

39 trials for Precancerous Condition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 5 unknown, 3 terminated, 1 withdrawn. 39 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 239Completed 30, Unknown 5, Terminated 3, Withdrawn 1
Phase 14Completed 2, Unknown 2
Phase 31Withdrawn 1

Follow Precancerous Condition: new trials by email Literature Review of Precancerous Condition trials Research Report on Precancerous Condition

Trials (filtered) newest first · largest first

All 39 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection
Multispectral Digital Colposcope (MDC) - Cervical Cancer, Precancerous Condition
Phase 2CompletedBritish Columbia Cancer Agency5512012-12-012019-07-05
Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
vandetanib, placebo, immunohistochemistry staining method - Lip and Oral Cavity Squamous Cell Carcinoma, Oral Cavity Verrucous Carcinoma
Phase 2CompletedUniversity of Chicago202012-01-012021-01-14
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis - Anal Cancer, Nonneoplastic Condition
Phase 2CompletedAIDS Malignancy Consortium1492011-06-282020-08-11
Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer
cetuximab, intensity-modulated radiation therapy (IMRT), Paclitaxel - Head and Neck Cancer, Precancerous Condition
Phase 2CompletedEastern Cooperative Oncology Group902010-08-112023-06-28
Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma
defined green tea catechin extract, gene expression analysis, protein analysis - Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
Phase 2TerminatedBarbara Ann Karmanos Cancer Institute82009-11-012015-03-27
Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy
broccoli sprout extract, placebo - Breast Cancer, Precancerous Condition
Phase 2CompletedOHSU Knight Cancer Institute542009-08-012017-04-27
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
questionnaire administration, comparison of screening methods, diagnostic endoscopic procedure - Esophageal Cancer, Precancerous Condition
Phase 1 / Phase 2UnknownUS Department of Veterans Affairs502009-05-012014-01-10
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
sulindac, placebo, laboratory biomarker analysis - Precancerous Condition
Phase 2CompletedNational Cancer Institute (NCI)502009-02-012017-12-26
Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders
anti-thymocyte globulin, busulfan, cyclophosphamide - Graft Versus Host Disease, Leukemia
Phase 2UnknownInstitut Paoli-Calmettes502008-01-012010-01-28
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
Gardasil - Infection, Precancerous Condition
Phase 2CompletedAIDS Malignancy Consortium1122007-11-012023-11-14
Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus
cidofovir, DNA methylation analysis, gene expression analysis - Anal Cancer, Precancerous Condition
Phase 2CompletedAIDS Malignancy Consortium332007-09-012015-12-21
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
darbepoetin alfa, epoetin alfa, fatigue assessment and management - Anemia, Leukemia
Phase 2CompletedMayo Clinic2392007-05-012017-02-10
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
anti-thymocyte globulin, cyclophosphamide, etoposide - Chronic Myeloproliferative Disorders, Graft Versus Host Disease
Phase 2CompletedCity of Hope Medical Center322007-05-012014-09-10
Lovastatin in Treating Patients At High Risk of Melanoma
lovastatin, placebo, biopsy - Precancerous Condition, Stage 0 Melanoma
Phase 2CompletedNational Cancer Institute (NCI)802007-05-012014-10-31
Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
cetuximab - Head and Neck Cancer, Precancerous Condition
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins352007-05-012020-03-12
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
acetylsalicylic acid, placebo, laboratory biomarker analysis - Colon Cancer, Precancerous Condition
Phase 2CompletedNational Cancer Institute (NCI)792007-03-012017-05-31
Folic Acid Clinical Trial for the Prevention of Cervical Cancer
folic acid, placebo - Cervical Cancer, Precancerous Condition
Phase 2CompletedUniversity of Alabama at Birmingham3682007-03-012015-10-08
Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia
defined green tea catechin extract, placebo - Lung Cancer, Precancerous Condition
Phase 2TerminatedBritish Columbia Cancer Agency232006-10-012012-03-09
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
sulindac, placebo - Precancerous Condition, Stage I Non-small Cell Lung Cancer
Phase 2CompletedNational Cancer Institute (NCI)612006-08-012014-05-23
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
tanespimycin - Chronic Myeloproliferative Disorders, Leukemia
Phase 2CompletedNational Institutes of Health Clinical Center (CC)372006-05-012012-03-15

Showing 20 of 39. Sign in to see all of them.

Narrower conditions

Precancerous Conditions (39)  ·  Monoclonal Gammopathy of Undetermined Significance (7)  ·  Multiple Myeloma (7)  ·  Neoplasms, Plasma Cell (7)  ·  Uterine Cervical Dysplasia (7)  ·  Burkitt Lymphoma (6)  ·  Leukemia (6)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (6)  ·  Lymphoma (6)  ·  Lymphoma, B-Cell, Marginal Zone (6)  ·  Lymphoma, Follicular (6)  ·  Lymphoma, Large B-Cell, Diffuse (6)  ·  Lymphoma, Large-Cell, Immunoblastic (6)  ·  Lymphoma, Mantle-Cell (6)  ·  Lymphoma, Non-Hodgkin (6)

Broader conditions

Neoplasms (39)  ·  Neoplasms by Site (24)  ·  Neoplasms by Histologic Type (14)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  DNA Virus Infections (10)  ·  Disease Attributes (10)  ·  Genital Diseases (10)  ·  Immune System Diseases (10)  ·  Pathologic Processes (10)  ·  Tumor Virus Infections (10)  ·  Urogenital Diseases (10)  ·  Virus Diseases (10)  ·  Blood Protein Disorders (9)  ·  Hematologic Diseases (9)  ·  Hemic and Lymphatic Diseases (9)

Interventions

Biopsy (3)  ·  Methotrexate (3)  ·  Sulindac (3)  ·  fludarabine phosphate (3)  ·  Antilymphocyte Serum (2)  ·  Busulfan (2)  ·  Celecoxib (2)  ·  Cetuximab (2)  ·  Cyclophosphamide (2)  ·  Cyclosporine (2)  ·  Epoetin Alfa (2)  ·  Gene Expression Profiling (2)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (2)  ·  Mycophenolic Acid (2)  ·  Peripheral Blood Stem Cell Transplantation (2)

Sponsors

National Cancer Institute (NCI) (5)  ·  AIDS Malignancy Consortium (3)  ·  British Columbia Cancer Agency (3)  ·  Mayo Clinic (2)  ·  OHSU Knight Cancer Institute (2)  ·  Roswell Park Cancer Institute (2)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)  ·  University of Alabama at Birmingham (2)  ·  Albert Einstein College of Medicine (1)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Children's Hospital of Philadelphia (1)  ·  City of Hope Medical Center (1)  ·  Dana-Farber/Brigham and Women's Cancer Center (1)  ·  Eastern Cooperative Oncology Group (1)

Countries

United States (36)  ·  Canada (4)  ·  France (1)  ·  Puerto Rico (1)

Top investigators

Joel Palefsky, MD (3)  ·  Michele Follen, MD, PhD (2)  ·  Stephen Lam, MD (2)  ·  Antonio T. Fojo, MD, PhD (1)  ·  Benn E. Smith, MD (1)  ·  Bobbie S. Gostout, MD (1)  ·  Carolyn D. Runowicz, MD (1)  ·  Chandrika J. Piyathilake, PhD, MPH (1)  ·  Charles L. Loprinzi, M.D. (1)  ·  Cornelia L. Trimble, MD (1)  ·  Craig A. Elmets, MD (1)  ·  Didier Blaise, MD (1)  ·  Elizabeth Stier, MD (1)  ·  Hector R. Nava, MD, FACS (1)  ·  Hemant Roy (1)

Results publications

PMID 17586030, PMID 19118066, PMID 19170225, PMID 20812850, PMID 21115882, PMID 21636546, PMID 21907959, PMID 23032420, PMID 23261228, PMID 25057165, PMID 26329135, PMID 26503631, PMID 26511489, PMID 28029303, PMID 30658128, PMID 31299087, PMID 34907980, PMID 4326367

NIH funding

P30CA015083 (3), U01CA121947 (3), N01CN35000 (2), P30CA006973 (2), P30CA023074 (2), N01CN35157 (1), N01CN35158 (1), N01CN35160 (1), P01CA027502 (1), P01CA082710 (1), P01CA096964 (1), P30CA016058 (1), P30CA016672 (1), P30CA022453 (1), P30CA033572 (1)